June 28 [ROOM 6]
08:40-09:00
Radiology Seminar. LI-RADS in Focus: Past, Present, and Future Challenges in HCC Imaging
/ Future Perspectives and New Challenges in LI-RADS
Hanyu JiangSichuan Univ., China
June 28 [ROOM 1]
09:50-10:10
KASL Symposium 1. Tailoring Hepatitis Management: From Antiviral Therapy to Post-Cure Surveillance
/ Precision Strategy for HCC Surveillance after Curing Hepatitis C: Debates across Guidelines
Tatsuya KantoNational Center for Global Health and Medicine, Japan
June 28 [ROOM 8]
10:10-10:30
KLTS-KAHBPS-KLCA Joint Symposium. Multidisciplinary Approaches for HCC with Bile Duct Invasion
/ Liver Resection and Transplantation
Xiao XuZhejiang Univ., China
June 28 [ROOM 2]
13:30-14:50
KLCA-JLCA Joint Symposium. Paving the Way Forward: Novel Immunotherapy Strategies for HCC
/ Chairperson
Michiie SakamotoKeio Univ., Japan
June 28 [ROOM 3]
13:30-13:50
KASL Symposium 3. Emerging Therapies and Diagnostics in Steatotic Liver Disease / Clinical Data Based on Old NAFLD and New MASLD: Shared vs. Separated
Mark MuthiahNational Univ. Hospital, Singapore
June 28 [ROOM 2]
13:50-14:10
KLCA-JLCA Joint Symposium. Paving the Way Forward: Novel Immunotherapy Strategies for HCC
/ Navigating the Post-Immunotherapy: Second-Line Options for HCC
Masatoshi KudoKindai Univ., Japan
June 28 [ROOM 2]
14:30-14:50
KLCA-JLCA Joint Symposium. Paving the Way Forward: Novel Immunotherapy Strategies for HCC
/ Predictive Biomarker Research of Combination Immunotherapy: Current Status and Future Perspectives
Takahiro KodamaOsaka Univ., Japan
June 28 [ROOM 3]
14:30-14:50
KASL Symposium 3. Emerging Therapies and Diagnostics in Steatotic Liver Disease
/ Tumor Immunity and Immunotherapeutic Susceptibility of Steatotic HCC
Tetsuo TakeharaOsaka Univ., Japan
June 28 [ROOM 3]
14:50-15:10
Special Interest Group 1. Critical Care Strategies for Acute-on-Chronic Liver Failure
/ Different Definitions and Prognostic Stratification of Acute-on-Chronic Liver Failure
June 29 [ROOM 1]
09:10-09:30
KASL Symposium 4. Portal Hypertension and Its Repercussions in Hepatic Care
/ Personalized Approach to Albumin Replacement in Decompensated Cirrhosis
Rakhi MaiwallInstitute of Liver and Biliary Sciences, India
June 28 [ROOM 4]
15:30-15:50
KLTS Symposium 3. Minimally Invasive Surgery for Recipients of Living Donor Liver Transplantation
/ Dr. Rela Institute Experience
Ashwin RammohanRela Hospital, India
June 29 [ROOM 4]
08:15-08:30
KAHBPS Symposium 1. Technical Advances in Minimally Invasive Liver Surgery
/ Hepatic Vein-Guided Anatomical Liver Resection
Wipusit TaesombatChulalongkorn Univ., Thailand
June 29 [ROOM 4]
09:10-09:30
KAHBPS Symposium 2. Biliary Pancreatic Disease in Cirrhotic Patients
/ Management of Acute Cholecystitis
Shang Yu WangChang Gung Memorial Hospital, Taiwan
June 29 [ROOM 2]
09:25-09:40
KLCA-TLCA Joint Symposium. East Meets Excellence: Exploring HCC Guidelines of Korea and Taiwan
/ AI Research of HCC in Taiwan
Yi-Hsiang HuangNational Yang Ming Chiao Tung Univ., Taiwan
June 29 [ROOM 2]
09:55-10:10
KLCA-TLCA Joint Symposium. East Meets Excellence: Exploring HCC Guidelines of Korea and Taiwan
/ Dissecting the Divergence: A Comparative Analysis of Stage-Specific HCC Treatment Approaches in Taiwan
I-Cheng LeeNational Yang Ming Chiao Tung Univ., Taiwan
June 29 [ROOM 7]
13:40-14:00
Special Interest Group 2. Navigating the Path to Hepatitis B Virus Eradication: Targets and Trials
/ Experimental in Vitro and in Vivo Models for Hepatitis B Virus Cure Research
Wenhui LiTsinghua Univ., China
June 29 [ROOM 1]
14:00-14:20
KASL Symposium 5. Personalized Approaches to Liver Disease
/ Virologic and Immunologic Biomarkers to Guide Treatment of Chronic Hepatitis B
Wai-Kay SetoThe Univ. of Hong Kong, Hong Kong
June 29 [ROOM 4]
14:00-14:20
KAHBPS Symposium 3. Surgical Liver Resection of HCC in Various Conditions
/ Overcoming Small Estimated Future Remnant Liver Volume
Alfred KowNational Univ. of Singapore, Singapore
June 29 [ROOM 8]
14:00-14:20
Special Interest Group 3. Advancing and Discovering Cures for Rare Liver Diseases
/ Overlap Syndrome: The Difference between Autoimmune Hepatitis and Primary Biliary Cirrhosis
Xiong MaShanghai Jiao Tong Univ., China
June 29 [ROOM 8]
14:20-14:40
Special Interest Group 3. Advancing and Discovering Cures for Rare Liver Diseases
/ Second-Line Pharmacotherapies for Hard-to-Treat Autoimmune Hepatitis and Primary Biliary Cirrhosis
Atsumasa KomoriNagasaki Univ., Japan
June 29 [ROOM 7]
14:20-14:40
Special Interest Group 2. Navigating the Path to Hepatitis B Virus Eradication: Targets and Trials
/ Promising Results for Curing Hepatitis B Virus: Viral and Immune Targets
Man-Fung YuenThe Univ. of Hong Kong, Hong Kong
June 28 [ROOM 3]
10:00-10:30
Special Symposium 1. Evolving Standards in Liver Disease Management: Guidelines from Theory to Practice
/ EASL Guidelines on Vascular Liver Disease
Pierre-Emmanuel RautouUniversité Paris-Cité, France
June 28 [ROOM 1]
14:50-15:10
KASL Symposium 2. Comprehensive Approaches in Alcohol-Related Liver Disease: From Genetics to Therapy
/ Genetic Vulnerabilities of Alcohol-Related Hepatitis and HCC in the East and West
June 29 [ROOM 1]
14:40-15:00
KASL Symposium 5. Personalized Approaches to Liver Disease / Molecular-Based Strategy for Atezo/Bev-Failed HCC: The 2025 French Medicine Genomic Program
Jean-Charles NaultSorbonne Université, France
June 29 [ROOM 1]
10:10-10:30
KASL Symposium 1. Tailoring Hepatitis Management: From Antiviral Therapy to Post-Cure Surveillance
/ Experimental Drugs and Therapeutic Endpoints of Chronic Hepatitis D
Maria ButiUniv. of Barcelona, Spain
June 29 [ROOM 2]
13:40-14:00
KLCA-KASL Joint Symposium. We Are Not Alone: Pioneering Combinational Approaches in HCC
/ Maximizing Early-Stage HCC Outcomes through Neoadjuvant and Adjuvant Strategies
Andrea CasadeiUniv. Vita-Salute San Raffaele, Italy
June 28 [ROOM 5]
08:00-08:15
Meet the Editor. CMH & AASLD Journals / Tips for Getting an Acceptance from AASLD Journals
June 29 [ROOM 1]
09:50-10:10
KASL Symposium 4. Portal Hypertension and Its Repercussions in Hepatic Care
/ Diagnostic Test and Available Therapy for Covert vs. Overt Hepatic Encephalopathy
Elliot B. TapperUniv. of Michigan, USA
June 28 [ROOM 5]
08:30-08:45
Meet the Editor. CMH & AASLD Journals / Hepatology Editor's Picks: Noticeable Publications in 2023-2024
June 28 [ROOM 1]
13:50-14:10
KASL-AASLD Joint Symposium. HCC Evolution: Understanding Risks and Therapeutic Approaches
/ Genomic and Epigenetic Clues to Persistent Risk of HCC after Curing Hepatitis C
Yujin HoshidaUniv. of Texas Southwestern Medical Center, USA
June 28 [ROOM 3]
09:30-10:00
Special Symposium 1. Evolving Standards in Liver Disease Management: Guidelines from Theory to Practice
/ AASLD Guidelines on Clinical Assessment and Management of MASLD
June 29 [ROOM 1]
10:50-11:20
State-of-the-Art Lecture. Advances in Non-Invasive Assessment of MASH
Rohit LoombaUniv. of California San Diego, USA
June 28 [ROOM 4]
09:30-09:50
KLTS Symposium 1. Beyond Boundaries: The Promise of Liver Transplants in Unusual Situations
/ Perihilar Cholangiocarcinoma: Current Strategy and Future Directions
June 28 [ROOM 1]
15:50-16:10
KASL Symposium 2. Comprehensive Approaches in Alcohol-Related Liver Disease: From Genetics to Therapy
/ Optimal Timing of Liver Transplantation in Severe Alcoholic Hepatitis
Julie K. HeimbachMayo Clinic, USA
June 28 [ROOM 1]
11:10-11:40
Commemorative Lecture. The Journey of a Hepatologist
June 29 [ROOM 3]
14:00-14:20
Special Symposium 3. Predictive Analytics and Risk Assessment
/ The Evolution and Implications of MELD Score: Version 3.0
W. Ray KimStanford Univ., USA
June 28 [ROOM 1]
14:30-14:50
KASL-AASLD Joint Symposium. HCC Evolution: Understanding Risks and Therapeutic Approaches
/ Guidelines and Evidence-Based Recommendations for Sequential Systemic Therapy of HCC
June 29 [ROOM 3]
14:20-14:40
Special Symposium 3. Predictive Analytics and Risk Assessment / Analytic Morphomics for Predicting Outcomes of Liver Disease
Grace L. SuUniv. of Michigan, USA
June 28 [ROOM 3]
15:30-15:50
Special Interest Group 1. Critical Care Strategies for Acute-on-Chronic Liver Failure
/ Management of Organ Failure and Infection in Critically-ill Patients with Acute-on-Chronic Liver Failure
June 29 [ROOM 5]
08:15-08:30
KASL-AASLD Morning Workshop. Impact of Early TIPS for the Management of Variceal Bleeding
/ Better
Guadalupe Garcia-TsaoYale Univ., USA
June 29 [ROOM 3]
09:30-09:50
Special Symposium 2. The MASH-HCC Nexus: From Epidemiology to Clinical Outcomes
/ Immune and Molecular Pathophysiology of MASH-HCC
June 29 [ROOM 1]
13:10-13:40
President's Choice Lecture. TBD
Tim F. GretenNational Cancer Institute, USA
June 29 [ROOM 2]
14:40-15:00
KLCA-KASL Joint Symposium. We Are Not Alone: Pioneering Combinational Approaches in HCC
/ Navigating Future Prospects for Triple Systemic Therapies in HCC
Richard S. FinnUniv. of California Los Angeles, USA
